Each tablet contains:
Extract of fresh Horse chestnut (Aesculus hippocastanum L.) seed(ratio 5:1)... 191.25 mg,
equivalent to 956.25 mg dried seed, standardized to 50 mg (22-32%)
aescine per tablet.
Microcrystalline cellulose, corn starch, methacrylic acid copolymer, copovidone, colloidal silicon dioxide, soya polysaccharides, talc, triethyl citrate.
Adults: Take 1 tablet twice daily every 12 hours with water during meals.
Some people may experience headache, dizziness,
gastric irritation, or itchiness.
Consult a healthcare practitioner prior to use if you are pregnant
Avoid taking in case of known allergy to any of the ingredients in
If symptoms persist or worsen, consult a healthcare practitioner.
Do not use if safety seal is broken.
Keep out of reach of children.
1- Guillaume M, Padioleau F. Veinotonic effect, vascular protection, anti-inflammatory and free radical scavenging properties of Horse Chestnut extract. Arzneimittelforschung 1994;44:25-35.
2- Facino RM, Carini M, Stefani R, et al. Anti-elastase and anti-hyaluronidase activities of saponins and sapogenins from Hedera helix, Aesculus hippocastanum, and Ruscus aculeatus: factors contributing to their efficacy in the treatment of venous insufficiency. Arch Pharm (Weinheim) 1995;328:720-724.
3- Matsuda H, Li Y, Murakami T, et al. Effects of escins Ia, Ib, IIa, and IIb from Horse Chestnut, the seeds of Aesculus hippocastanum L., on acute inflammation in animals. Biol Pharm Bull 1997;20:1092-1095.
4- Brunner F, Hoffmann C, Schuller-Petrovic S. Responsiveness of human varicose saphenous veins to vasoactive agents. Br J Clin Pharmacol 2001 Mar;51(3):219-24.
5- Pittler MH, Ernst E. Horse-chestnut seed extract for chronic venous insufficiency. A criteria-based systematic review. Arch Dermatol 1998 Nov;134(11):1356-60
6- Diehm C, Trampisch HJ, Lange S, Schmidt C. Comparison of leg compression stocking and oral horse-chestnut seed extract therapy in patients with chronic venous insufficiency. Lancet 1996;347:292-294
7- Shah D, Bommer S, Degenring FH. Aesculaforce (Venaforce in Canada) in chronic venous insufficiency. Schweiz Zschr GanzheitMedizin 1997;9(2):86-91.
Disclaimer: This content is subject to change. The information is intended to inform and educate; it does not replace the medical evaluation, advice, diagnosis or treatment by a healthcare professional. www.nhpassist.com © 2014 NDAssist Inc. and/or its affiliates. All rights reserved.